Page last updated: 2024-11-06

4-tolylsulfonylurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-tolylsulfonylurea: structure given in first source; the major metabolite of tolbutamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74327
SCHEMBL ID170426
MeSH IDM0221423

Synonyms (39)

Synonym
1694-06-0
EC-000.1456
4-methylphenylsulfonylurea ,
OPREA1_528210
4-tolylsulfonylurea
(4-methylphenyl)sulfonylurea
n-carbamoyl-4-methylbenzenesulfonamide
4,7,7-trimethylnorbornan-2-ol;n-carbamoyl-4-methylbenzenesulfonamide
A811098
AKOS003624899
p-toluenesulfonylurea
T2890
n-(aminocarbonyl)-4-methylbenzenesulphonamide
p-tolylsulfonylurea
einecs 216-900-3
q9w3k7k5xb ,
unii-q9w3k7k5xb
FT-0633778
FS-3527
(4-methylbenzenesulfonyl)urea
4-toluenesulfonylurea
AM20030131
PB29041
SCHEMBL170426
p-toluolsulfonyl-harnstoff
DS-1957
benzenesulfonamide, n-(aminocarbonyl)-4-methyl-
DTXSID90168704
n-(p-toluenesulfonyl)urea
J-523530
4-toluenesulfonylurea, aldrichcpr
mfcd00196522
J-010537
toluenesulfonylurea [ep impurity]
toluenesulfonylurea
tolbutamide impurity b [ep impurity]
1-((4-methylphenyl)sulfonyl)urea
SY052679
CS-W014932
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]